Pinsent Masons advises Medical Properties Trust on £347m acquisition of eight UK hospitals

24 Jul 2019 | 09:30 am | 1 min. read

International law firm Pinsent Masons has advised specialist hospitals REIT investor Medical Properties Trust on its £347m unconditional acquisition from Secure Income REIT plc of a portfolio of eight hospitals in the UK operated by Ramsay Healthcare UK.

This latest transaction through a corporate structure builds on MPT’s acquisition of the BMI-operated hospital at Poole, Dorset earlier this year that Pinsent Masons also acted on.

The Pinsent Masons team advising on the deal was led by corporate Partner Robert Moir, working with Real Estate Partner Tom Eastwood, tax senior consultant Richard Croker, Senior Associate Sandra Plantier, Associates Finlay Fraser, Rebecca Shenkin, James Tryfonos, Gary Parmley and Trainee Damini Kotecha.

The hospitals are Ashtead Hospital Surrey, Berkshire Independent Hospital Reading, Euxton Hall Hospital Lancashire, Mount Stuart Hospital Torquay, North Downs Hospital Surrey, Renacres Hospital Lancashire, Rowley Hospital Stafford and Winfield Hospital Gloucester.

Arendt advised MPT on Luxembourg aspects and Taylor Wessing acted for the seller.

Commenting on the transaction, Robert Moir said: “We are delighted to have advised MPT on this significant strategic acquisition, as they continue to grow their investment portfolio of hospital assets globally. The deal reflects the continued international appetite for strong UK real estate assets backed by institutional long leases”.

Managing Director of International Acquisitions and Operations at MPT, Luke Savage, said: “This acquisition came together quickly with a short timeline, and we were very impressed with the responsiveness and quality of advice that we received from Robert Moir and his team at Pinsent Masons. This is the third opportunity we have enjoyed working with PM in the past year and we look forward to future transactions as we continue to expand our hospital portfolio in the UK.”

Latest press releases

Show me all press releases

Pinsent Masons appointed to Government legal panel for public sector

Multinational law firm Pinsent Masons has been named as a supplier on Government Commercial Agency’s (GCA) RM6374 Legal Panel for Public Sector framework, a major legal services framework expected to be a key route to market for public sector organisations across the UK over the coming years.

Pinsent Masons advises FTI Consulting on sale of CX Lavender key client business to Omnicom Oceania

Multinational law firm Pinsent Masons has advised FTI Consulting, in its capacity as administrators of the CX Lavender group, on the sale of the company's key client-related business and associated workforce to Omnicom Oceania via its subsidiary, Clemenger BBDO Pty Ltd. The transaction completed in Q2 2026.

Pinsent Masons advises University of Manchester on landmark student accommodation redevelopment

Multinational law firm Pinsent Masons has advised The University of Manchester on the largest student accommodation design, build, finance and operate (DBFO) project ever undertaken by a UK university.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises FTI Consulting on sale of CX Lavender key client business to Omnicom Oceania

Multinational law firm Pinsent Masons has advised FTI Consulting, in its capacity as administrators of the CX Lavender group, on the sale of the company's key client-related business and associated workforce to Omnicom Oceania via its subsidiary, Clemenger BBDO Pty Ltd. The transaction completed in Q2 2026.

Pinsent Masons advises University of Manchester on landmark student accommodation redevelopment

Multinational law firm Pinsent Masons has advised The University of Manchester on the largest student accommodation design, build, finance and operate (DBFO) project ever undertaken by a UK university.

Pinsent Masons advises Horizon 3 Healthcare on investment in Xeltis

Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.